Standout Papers
- Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes (2015)
- Efficacy and safety of the dipeptidyl peptidase‐4 inhibitor, sitagliptin, compared with the sulfonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: a randomized, double‐blind, non‐inferiority trial (2007)
Immediate Impact
3 by Nobel laureates 20 from Science/Nature 97 standout
Citing Papers
The road to fully programmable protein catalysis
2022 StandoutNatureNobel
The changing landscape of atherosclerosis
2021 StandoutNature
Works of Peter P. Stein being referenced
Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes
2015 Standout
Initial monotherapy with either metformin or sulphonylureas often fails to achieve or maintain current glycaemic goals in patients with Type 2 diabetes in UK primary care
2007
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Peter P. Stein | 4226 | 1722 | 1609 | 27 | 4.7k | |
| P. Fleck | 4198 | 1592 | 1435 | 38 | 4.6k | |
| Peter Öhman | 4912 | 1949 | 1594 | 32 | 5.4k | |
| Hans‐Juergen Woerle | 4004 | 1616 | 1866 | 59 | 4.3k | |
| M. Angelyn Bethel | 4201 | 1618 | 1452 | 39 | 4.9k | |
| Klaus A. Dugi | 2880 | 1401 | 1526 | 71 | 4.3k | |
| Craig Wilson | 2901 | 1103 | 947 | 27 | 3.2k | |
| S. Dejager | 4282 | 1654 | 2577 | 93 | 5.9k | |
| Mark Kipnes | 2815 | 1199 | 1291 | 56 | 4.1k | |
| Richard M. Bergenstal | 6348 | 2513 | 2121 | 30 | 7.3k | |
| Shailaja Suryawanshi | 2008 | 1066 | 966 | 28 | 3.5k |
All Works
Loading papers...